治皮肤癣阜阳哪家医院阜阳怎么治疗白斑好,阜阳检查干癣疾病医院,阜阳去豆印大概多少钱,嘴角长痘痘阜阳哪里看比较好,阜阳治疗顽固性湿诊,阜阳哪个痤疮医院好且实惠,阜阳市到哪里看皮肤病

CHANGSHA, Jan. 25 (Xinhua) -- More than 8,000 fake goods were destroyed Tuesday in central China's Hunan Province, as part of Chinese efforts to protect intellectual property rights (IPR).Supervised by Changsha customs official, trucks rolled over a huge pile of counterfeit electronic devices in the city, the provincial capital.The trucks crashed imitation Nokia, Motorola and Apple laptop computers, cell phones, earphones and compact discs.Pirated books and Gucci handbags were incinerated.Changsha customs have confiscated more than 34,000 fake items worth 1.3 million yuan (197,470 U.S. dollars) over the past two years, said Liu Zili, a customs official.Some confiscated fake goods were donated to Red Cross societies and quake-devastated regions, in accordance with China's IPR protection regulations.

BEIJING, Jan. 22 (Xinhua) -- Chinese President Hu Jintao's latest state visit to the United States bore rich fruit and opened a new chapter of cooperation between the two countries, Foreign Minister Yang Jiechi said Saturday.The tour, from Tuesday through Friday, came at the beginning of the second decade of the 21st century, on the 40th anniversary of the resumption of contact between the two countries and on the opening year of China's 12th five-year plan for national socioeconomic development, Yang noted.Meanwhile, the international situation was witnessing deep and complicated changes, and the China-U.S. relationship was forging ahead with increasing momentum while inevitably encountering some differences and disputes, he said.Against such a backdrop, the Chinese president held frank and in-depth talks with his U.S. counterpart, Barack Obama, and many other senior political figures, and reached important consensus on bilateral relations and a host of major regional and global affairs, Yang said.During the tightly scheduled trip, which saw Hu attend nearly 20 events in Washington and Chicago within 68 hours, the Chinese leader also reached out to the U.S. public, conveying China's resolution to advance China-U.S. ties, highlighting China's commitment to peaceful development and presenting China's image of peace, development, opening-up and progress, Yang said.The U.S. and international media, he added, attached great importance to and spoke highly of Hu's trip, hailing it as a historic visit at a crucial moment and whose significance was manifested partly in the top level reception with full pomp and ceremony given by the U.S. government.In summary, the latest step in China-U.S. diplomacy achieved rich results and cast a far-reaching influence not only upon the two countries themselves but upon the whole world, the Chinese foreign minister said.

WASHINGTON, April 25 (Xinhua) -- A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.Working in cell lines from colorectal cancer patients, researchers found that the class of drugs called PARP inhibitors worked against tumors with mutations in the MRE11 gene.About 15 percent of all colorectal cancers have what's called microsatellite instability, a type of error in the DNA. About 82 percent of those tumors have the MRE11 gene mutation."This is a potential broader application for PARP inhibitors, beyond breast and ovarian cancer. This is a class of drug that's already shown safety in early clinical trials and now might benefit some colorectal cancer patients as well," says lead study author Eduardo Vilar-Sanchez, a hematology/oncology fellow at the university, in a statement.The study, which was published Monday in Cancer Research, also found that PARP inhibitors are even more effective when both copies of MRE11 were mutated. Each person carries two copies of each gene, which means mutations can occur in either one or both copies. The researchers suggest that PARP inhibitors could be targeted specifically to colorectal cancer patients who have two copies of the mutated gene.Researchers are planning a phase I clinical trial to look at using PARP inhibitors in colorectal cancer patients with two mutated copies of MRE11. Future trials are being considered using PARP inhibitors to prevent colorectal cancer and other cancers in people with Lynch syndrome whose tumors have this mutation.Microsatellite instability is also seen in prostate cancer and endometrial cancer, suggesting potential for PARP inhibitors to play a role in additional types of cancer as well, Vilar-Sanchez says, adding that more research is needed in these areas.

BEIJING, Feb. 14 (Xinhua) -- China's meteorological authority announced on Monday that it has received 7.5 million yuan from the country's Ministry of Finance to strengthen its efforts in fighting persistent drought in some regions.The fund would be used to support efforts by meteorological departments in Shanxi, Hebei, Anhui, Shandong, and Henan provinces, all major crop-producing regions, to conduct activities for seeding clouds and making artificial rain, according to a statement posted on the National Meteorological Administration website.Government data shows that a prolonged drought since last October had affected 108.24 million mu (7.22 million hectares) of wheat crops in those provinces, as well as Jiangsu, Shaanxi and Gansu provinces, as of Sunday.The statement added that some of the affected regions experienced two rounds of snowfall last week, which were helpful in alleviating the drought. However, the major wheat-growing provinces of Shandong and Henan recorded no rainfall.The country's meteorological authority also predicted no significant rainfall or heavy snowfall for the dry regions over the next three days. (One U.S. dollar equals roughly 6.6 yuan.) 

WASHINGTON, May 3 (Xinhua) -- People diagnosed with asthma in the United States grew by 4.3 million between 2001 and 2009, according to a new report released Tuesday by the Centers for Disease Control and Prevention (CDC).In 2009, nearly one in 12 Americans were diagnosed with asthma. In addition to increased diagnoses, asthma costs grew from about 53 billion U.S. dollars in 2002 to about 56 billion dollars in 2007, about a six percent increase. The explanation for the growth in asthma rates is unknown, according to the CDC.Asthma is a lifelong disease that causes wheezing, breathlessness, chest tightness, and coughing, though people with asthma can control symptoms and prevent asthma attacks by avoiding things that can set off an asthma attacks, and correctly using prescribed medicine, like inhaled corticosteroids. The report highlights the benefits of essential asthma education and services that reduce the impact of these triggers, but most often these benefits are not covered by health insurers."Despite the fact that outdoor air quality has improved, we've reduced two common asthma triggers -- secondhand smoke and smoking in general -- asthma is increasing," said Paul Garbe, chief of CDC 's Air Pollution and Respiratory Health Branch. "While we don't know the cause of the increase, our top priority is getting people to manage their symptoms better."Asthma triggers are usually environmental and can be found at school, work, home, outdoors, and elsewhere and can include tobacco smoke, mold, outdoor air pollution, and infections linked to influenza, cold-like symptoms, and other viruses.According to the report, asthma diagnoses increased among all demographic groups between 2001 and 2009, though a higher percentage of children reported having asthma than adults (9.6 percent compared to 7.7 percent in 2009). Annual asthma costs in the United States were 3,300 dollars per person with asthma from 2002 to 2007 in medical expenses. About two in five uninsured and one in nine insured people with asthma could not afford their prescription medication."Asthma is a serious, lifelong disease that unfortunately kills thousands of people each year and adds billions to our nation's health care costs," said CDC Director Thomas Frieden. "We have to do a better job educating people about managing their symptoms and how to correctly use medicines to control asthma so they can live longer more productive lives while saving health care costs."